FDA Investigates Island Soup Company
date:Sep 28, 2016
can support the growth of Clostridium botulinum bacteria.

The facility was inspected in July 2015. After that inspection, Island Soups Company signed an affidavit stating that it would cease production and distribution until it met FDA regulations, including filing scheduled processes for thermally-processed LACF products.

As of the date of the September 2016 FDA notice, Island Soups Company has not filed scheduled processes for these products. And the company continued to distribute soups to
3/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/22 15:02